Grifols (WBO:GRF) GF Score: 82/100 (As of Jul. 08, 2026) — Near Median


WBO:GRF Grifols SA WBO:GRF
82 GF Score
Price €9.07
GF Value €11.00
! 7 Warning Signs
View Full Analysis

What is Grifols GF Score?

Grifols WBO:GRF +0.11% 82 GF Score is 82 as of Jul. 08, 2026, which is 8% above its 10-year median of 76.00. GuruFocus rates WBO:GRF with a GF Score™ of 82/100 and a GF Value™ of €11.00. The stock has 7 warning signs investors should review.

Grifols has the GF Score of 82, which implies that the company might have Good outperformance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 3/10
2. Profitability Rank : 8/10
3. Growth Rank : 8/10
4. GF Value Rank : 8/10
5. Momentum Rank : 4/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Grifols might have Good outperformance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Grifols  (WBO:GRF) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Grifols GF Score Related Terms

WBO:GRF vs LLY, JNJ, ABBV: GF Score Comparison

For the Drug Manufacturers - General subindustry, Grifols's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grifols GF Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grifols's GF Score distribution charts can be found below:

* The bar in red indicates where Grifols's GF Score falls into.


WBO:GRF
82GF Score
Grifols SA WBO:GRF
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 82 mean?
Grifols (WBO:GRF) has a GF Score of 82 as of Jul. 08, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Grifols and its competitors. This is near median its historical median of 76.00. Over the past decade, Grifols' GF Score has ranged from 26.00 to 100.00.
Is Grifols' GF Score too high?
Grifols' current GF Score of 82 is near median its 10-year median of 76.00. Over the past 10 years, this metric has ranged from a low of 26.00 to a high of 100.00. Overall, Grifols has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Grifols' GF Score compare to LLY and JNJ?
Grifols' GF Score of 82 can be compared against companies in the Drug Manufacturers industry. Historically, Grifols' own GF Score has ranged from 26.00 to 100.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Grifols and its competitors. Grifols's current GF Score is 82, which is near median its own 10-year median of 76.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grifols stock overvalued right now?
Grifols (WBO:GRF) has a current GF Score of 82. The stock's GF Value™ is €11.00, compared to a current price of €9.07 — trading 17.6% below its estimated fair value. The current GF Score is 82, which is near median its 10-year median of 76.00. Grifols' overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Grifols (WBO:GRF), the current GF Score is 82 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grifols (WBO:GRF) Overvalued in 2026?

Based on GuruFocus' analysis, Grifols stock appears to be undervalued. The current stock price of €9.07 is trading 17.6% below its estimated GF Value™ of €11.00.

Key valuation signals for WBO:GRF:

  • GF Score: 82 (near median its 10-year median of 76.00)
  • GF Value™: €11.00 vs. price of €9.07 (17.6% below fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the WBO:GRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Grifols Business Description

Address Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
82GF Score

Get the complete analysis for WBO:GRF

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.07
Price
€11.00
GF Value